Pfizer Inc (PFE)
25.52
+0.26
(+1.05%)
USD |
NYSE |
Apr 26, 12:40
Pfizer Market Cap: 144.13B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 142.64B |
| April 24, 2024 | 148.34B |
| April 23, 2024 | 148.62B |
| April 22, 2024 | 148.28B |
| April 19, 2024 | 146.82B |
| April 18, 2024 | 143.37B |
| April 17, 2024 | 143.54B |
| April 16, 2024 | 145.07B |
| April 15, 2024 | 146.31B |
| April 12, 2024 | 146.03B |
| April 11, 2024 | 148.74B |
| April 10, 2024 | 148.62B |
| April 09, 2024 | 151.22B |
| April 08, 2024 | 150.09B |
| April 05, 2024 | 150.54B |
| April 04, 2024 | 150.49B |
| April 03, 2024 | 153.71B |
| April 02, 2024 | 155.57B |
| April 01, 2024 | 156.53B |
| March 28, 2024 | 156.70B |
| March 27, 2024 | 156.87B |
| March 26, 2024 | 155.79B |
| March 25, 2024 | 154.89B |
| March 22, 2024 | 154.50B |
| March 21, 2024 | 156.19B |
| Date | Value |
|---|---|
| March 20, 2024 | 156.42B |
| March 19, 2024 | 156.02B |
| March 18, 2024 | 156.53B |
| March 15, 2024 | 157.77B |
| March 14, 2024 | 158.84B |
| March 13, 2024 | 159.35B |
| March 12, 2024 | 158.17B |
| March 11, 2024 | 160.20B |
| March 08, 2024 | 153.71B |
| March 07, 2024 | 151.28B |
| March 06, 2024 | 153.54B |
| March 05, 2024 | 147.27B |
| March 04, 2024 | 146.20B |
| March 01, 2024 | 150.15B |
| February 29, 2024 | 149.98B |
| February 28, 2024 | 152.69B |
| February 27, 2024 | 151.84B |
| February 26, 2024 | 153.48B |
| February 23, 2024 | 156.75B |
| February 22, 2024 | 155.57B |
| February 21, 2024 | 156.25B |
| February 20, 2024 | 155.79B |
| February 16, 2024 | 155.96B |
| February 15, 2024 | 155.34B |
| February 14, 2024 | 153.06B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
142.64B
Minimum
Apr 25 2024
343.79B
Maximum
Dec 16 2021
221.17B
Average
210.48B
Median
Market Cap Benchmarks
| Amgen Inc | 144.66B |
| Gilead Sciences Inc | 81.92B |
| Johnson & Johnson | 353.15B |
| Viking Therapeutics Inc | 7.569B |
| Moderna Inc | 41.09B |
Market Cap Related Metrics
| PE Ratio | 70.90 |
| PS Ratio | 2.480 |
| Price to Book Value | 1.619 |
| Price to Free Cash Flow | 30.26 |
| Price | 25.52 |
| Earnings Yield | 1.41% |
| Operating PE Ratio | 43.19 |
| Normalized PE Ratio | 23.98 |